Oncology Nursing News Top Stories: March 2021

Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from March 2021.

5. Immunotherapy and ADCs Make Headway in Metastatic TNBC

Anthracyclines and taxanes remain a backbone in the early-stage setting of triple-negative breast cancer as further evaluations of immunotherapy in the neoadjuvant and adjuvant settings needs to be conducted—efforts that will continue to shape the treatment paradigm.

4. New Treatment Methods Launch a Shift in CRC Treatment

When it comes to colorectal cancer, Tony Philip, MD, provides insight into the utility of ctDNA in the early-stage setting, trials that could determine its role in clinical practice, and detailed the shift toward nonoperative and less-intensive interventions in the early-stage and advanced settings, respectively.

3. Updates Change HER2-Positive Breast Cancer Treatment

In this story, learn more about how The KATHERINE, FeDeriCa, DESTINY-Breast01, and HER2CLIMB trials have changed practice for patients with HER2-positive breast cancer for the better.

2. Frontline CLL Treatment: What's the Right Approach?

The treatment paradigm for chronic lymphocytic leukemia has expanded beyond continuous treatment with BTK inhibitors with the addition of the time-limited regimen of venetoclax plus obinutuzumab.

1. Study Explores Actionable Pathologic Variants in Caribbean Women With Breast or Ovarian Cancer

Here, we examine recent data that found that one in 7 Caribbean-born individuals with either breast or ovarian cancer had hereditary disease with an actionable pathogenic variant, which provides the opportunity for the utilization of targeted therapeutics and precise prevention strategies.

Thanks for reading!